Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 15.68%23.04M | 70.92%50.75M | 159.56%19.92M | 182.55%29.69M | 263.61%14.61M | 185.45%7.67M | 33.56%1.76M | 37.67%10.51M | -27.56%4.02M | -10.57%2.69M |
| Operating income | 15.68%23.04M | 70.92%50.75M | 159.56%19.92M | 182.55%29.69M | 263.61%14.61M | 185.45%7.67M | 33.56%1.76M | 37.67%10.51M | -27.56%4.02M | -10.57%2.69M |
| Cost of sales | -15.37%-12.1M | -45.17%-27.3M | -42.23%-10.49M | -76.60%-18.8M | -115.39%-10.99M | -106.74%-7.37M | -30.79%-2.03M | -56.99%-10.65M | -3.15%-5.1M | -46.10%-3.57M |
| Operating expenses | -15.37%-12.1M | -45.17%-27.3M | -42.23%-10.49M | -76.60%-18.8M | -115.39%-10.99M | -106.74%-7.37M | -30.79%-2.03M | -56.99%-10.65M | -3.15%-5.1M | -46.10%-3.57M |
| Gross profit | 16.03%10.94M | 115.39%23.45M | 3,038.27%9.43M | 7,917.92%10.89M | 435.44%3.63M | 134.22%300.52K | -14.83%-262.76K | -116.38%-139.28K | -279.32%-1.08M | -255.46%-878.11K |
| Impairment and provision | -14,201.15%-111.84K | -141.50%-446.11K | 99.74%-782 | 1,228.93%1.08M | 44.90%-294.22K | 43.90%-299.76K | -187.48%-5.17K | 98.22%-95.23K | -64,008.04%-534.02K | -43.53%-534.35K |
| -Other impairment is provision | -14,201.15%-111.84K | -141.50%-446.11K | 99.74%-782 | 1,228.93%1.08M | 44.90%-294.22K | 43.90%-299.76K | -187.48%-5.17K | 97.08%-95.23K | -64,008.04%-534.02K | -43.53%-534.35K |
| Special items of operating profit | -8.06%-10.84M | -41.67%-20.23M | -41.17%-10.03M | 6.97%-14.28M | 10.56%-10.41M | 14.33%-7.1M | 13.16%-3.49M | 17.07%-15.35M | 14.08%-11.64M | 13.14%-8.29M |
| Operating profit | 98.95%-6.29K | 220.11%2.78M | 91.58%-598.26K | 85.15%-2.31M | 46.60%-7.08M | 26.81%-7.1M | 11.40%-3.76M | 32.23%-15.58M | -2.39%-13.26M | -3.75%-9.7M |
| Financing cost | 37.26%-81.39K | -132.83%-238.67K | -362.53%-129.73K | -11.55%-102.51K | 48.89%-38.75K | 49.85%-28.05K | 40.73%-14.78K | -7.32%-91.89K | -29.94%-75.82K | -35.80%-55.93K |
| Earning before tax | 87.96%-87.68K | 205.14%2.54M | 89.79%-727.99K | 84.58%-2.42M | 46.61%-7.12M | 26.94%-7.13M | 11.57%-3.77M | 32.08%-15.67M | -2.52%-13.33M | -3.89%-9.76M |
| Tax | 26.48%112.64K | 152.16%1.22M | --89.06K | -48.16%483.13K | ---- | ---- | ---- | --932.04K | ---- | ---- |
| After-tax profit from continuing operations | 103.91%24.96K | 294.42%3.76M | 91.04%-638.93K | 86.89%-1.93M | 46.61%-7.12M | 26.94%-7.13M | 11.57%-3.77M | 36.12%-14.74M | -2.52%-13.33M | -3.89%-9.76M |
| Earning after tax | 103.91%24.96K | 294.42%3.76M | 91.04%-638.93K | 86.89%-1.93M | 46.61%-7.12M | 26.94%-7.13M | 11.57%-3.77M | 36.12%-14.74M | -2.52%-13.33M | -3.89%-9.76M |
| Profit attributable to shareholders | 103.91%24.96K | 294.42%3.76M | 91.04%-638.93K | 86.89%-1.93M | 46.61%-7.12M | 26.94%-7.13M | 11.57%-3.77M | 36.12%-14.74M | -2.52%-13.33M | -3.89%-9.76M |
| Basic earnings per share | 0 | 300.00%0.0038 | 91.55%-0.0006 | 87.07%-0.0019 | 0.00%-0.01 | 27.55%-0.0071 | 0.00%-0.004 | 36.36%-0.0147 | 0.00%-0.01 | -4.26%-0.0098 |
| Diluted earnings per share | 0 | 300.00%0.0038 | 91.55%-0.0006 | 87.07%-0.0019 | 27.55%-0.0071 | 36.36%-0.0147 | -4.26%-0.0098 | |||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Accounting Firm | -- | -- | -- | Grant Thornton (Hong Kong) Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.